CRISPR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. 

CEO
Samarth Kulkarni
CEOSamarth Kulkarni
Employees
407
Employees407
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2013
Founded2013
Employees
407
Employees407

CRSP Key Statistics

Market cap
4.39B
Market cap4.39B
Price-Earnings ratio
-17.96
Price-Earnings ratio-17.96
Dividend yield
Dividend yield
Average volume
1.59M
Average volume1.59M
High today
$53.26
High today$53.26
Low today
$51.01
Low today$51.01
Open price
$51.40
Open price$51.40
Volume
910.07K
Volume910.07K
52 Week high
$91.10
52 Week high$91.10
52 Week low
$43.42
52 Week low$43.42

CRSP News

TipRanks 2d
Crispr Therapeutics reports Q3 EPS ($1.01), consensus ($1.42)

Reports Q3 revenue $602,000, consensus $6.81M. “We continue to make significant progress across our pipeline of in vivo and ex vivo CRISPR-based therapies,” sai...

Analyst ratings

52%

of 31 ratings
Buy
51.6%
Hold
38.7%
Sell
9.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.